Scientists at the Children’s Hospital Oakland Research Institute (CHORI) Nutrition & Metabolism Center recently announced that they have developed a low-calorie, high-fiber, fruit-based vitamin and mineral nutrition bar called the CHORI-bar, which improves biomarkers linked to risk of cardiovascular disease, cognitive decline, and associated decline in antioxidant defenses.
Nutrition Bar Improves Metabolic Biomarkers Linked to Cardiovascular Disease, Cognitive Decline and Anti-Oxidant Defenses
Low levels of physical activity — like the 5,000 steps per day that Americans typically achieve, which is only about half of the recommended amount — have been implicated in the development of insulin resistance and its progression to full blown type 2 diabetes. However, the studies that suggested this connection were performed under laboratory conditions; they did not use people eating real meals, and they did not assess glycemic variability, so the direct impact of physical activity on glycemic control is not completely clear.
Elevated postprandial glucose (PPG) often precedes the development of type 2 diabetes, and is a risk factor for adverse cardiovascular events, independently of diabetes status. Thus, Dr. Catherine Mikus and her colleagues at the University of Missouri set out to precisely define the impact of reducing physical activity on PPG and glycemic variability in healthy, active volunteers as they went about their daily lives. The results of their study were recently published in the journal Medicine and Science in Sports and Exercise .
In the United States, 23.6 million children and adults — 7.8% of the population — have diabetes and one-third of U.S. adults are obese [1-2]. Obesity is associated with an increased risk of developing type 2 diabetes as well as insulin resistance, a condition that precedes the development of type 2 diabetes. New research published in the Journal of Nutrition now suggests that blueberries can help improve insulin sensitivity in obese, non-diabetic and insulin-resistant people .
An international research consortium has found 13 new genetic variants that influence blood glucose regulation, insulin resistance, and the function of insulin-secreting beta cells in populations of European descent. Five of the newly discovered variants increase the risk of developing type 2 diabetes, the most common form of diabetes.